share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer SAHNI PAYAL

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer SAHNI PAYAL

輝瑞 | 4:持股變動聲明-高管 SAHNI PAYAL
美股SEC公告 ·  09/17 00:56

牛牛AI助理已提取核心訊息

Pfizer Inc. (PFE) Executive Vice President, Payal Sahni, was reported to have engaged in a transaction involving the company's stock on September 12, 2024. However, the specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and total value of shares, were not disclosed in the announcement. The address of the reporting person is listed as 66 Hudson Boulevard East, New York, NY, 10001-2192. Without the transaction details, the impact on Sahni's total number of shares held after the action remains unclear.
Pfizer Inc. (PFE) Executive Vice President, Payal Sahni, was reported to have engaged in a transaction involving the company's stock on September 12, 2024. However, the specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and total value of shares, were not disclosed in the announcement. The address of the reporting person is listed as 66 Hudson Boulevard East, New York, NY, 10001-2192. Without the transaction details, the impact on Sahni's total number of shares held after the action remains unclear.
報告稱,輝瑞公司(PFE)執行副總裁Payal Sahni據稱已於2024年9月12日參與了涉及該公司股票的交易。不過,公告中未披露具體交易細節,如行動類型、狀態、股票數量、股票性質、交易價格以及股票總價值。報告人的地址被列爲紐約市曼哈頓,郵編10001-2192的66 Hudson Boulevard East。由於缺乏交易細節,該行動對Sahni擁有的股份總數的影響仍不明確。
報告稱,輝瑞公司(PFE)執行副總裁Payal Sahni據稱已於2024年9月12日參與了涉及該公司股票的交易。不過,公告中未披露具體交易細節,如行動類型、狀態、股票數量、股票性質、交易價格以及股票總價值。報告人的地址被列爲紐約市曼哈頓,郵編10001-2192的66 Hudson Boulevard East。由於缺乏交易細節,該行動對Sahni擁有的股份總數的影響仍不明確。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。